GL1X · GenesisL1 explorer

Research workbench

Influenza neuraminidase in complex with a novel antiviral compound

Analyse Influenza neuraminidase in complex with a novel antiviral compound in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4MJU
Type
protein
Length
389 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Neuraminidase
EC
3.2.1.18
UniProt
Q07599
Ligands
27S, CA
Pockets
2 · best druggability 0.65

Structure

x-ray diffraction · 1 distinct chain · 5% helix, 46% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANeuraminidase (EC 3.2.1.18)protein3895% helix, 46% strandQ07599

Ligands and binding sites

  • 27S · (5R,9R,10S)-10-(acetylamino)-2-amino-4-oxo-9-(pentan-3-yloxy)-1-thia-3-azaspiro[4.5]deca-2,6-diene-7-carboxylic acid · ligand · chains A
  • CA · Calcium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14270.650.795227S
2640.320.7514empty

Modifications

Observed in the structure: 8 disulfide (disulfide).

Compared structures

  • 4MJU · Influenza Neuraminidase in complex with a novel antiviral compound · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.